Home > Name List By n > N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2- methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine

CAS No 231277-92-2 , N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-
methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine

  • Name: N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-
    methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
  • Synonyms: Lapatinib tosilate hydrate;Tykerb; 1xkk; Lapatinib (INN); GW 572016;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-
    methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine; Tycerb; Lapatinib [INN]; 231277-92-2; GW572016;
  • CAS Registry Number:
  • Density: 1.381 g/cm3
  • Refractive index: 1.645
  • Molecular Weight: 581.057543
  • InchiKey: BCFGMOOMADDAQU-UHFFFAOYSA-N
  • InChI: InChI=1S/C29H26ClFN4O4S/c1-40(36,
    37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-
    6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,
    16-17H2,1H3,(H,33,34,35)
  • Molecular Formula: C29H26ClFN4O4S
  • Molecular Structure:CAS No:231277-92-2 N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-<br />methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine

Related products

Search by region :

Select to

231277-92-2 Lapatinib base

  • China Nanjing Ange Pharmaceutical Co., Ltd. null
  • Fax: +86-25-86501191
  • Address: Room 2309-2311, Technical garden B place, Industrial university, NO.5 Xinmofang Road, Nanjing, China null,nullChina
Contact Supplier

231277-92-2 LAPATINIB

Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

  • China Hangzhou Hysen Pharma [Importer/Exporter]
  • Tel: +86-571-89937383
  • Fax: +86-571-89937383
  • Address: No.808, B Building,Zijin Plaza, No.701,Gudun ROAD,Hangzhou CHINA-310012 HANGZHOU,ZHEJIANGChina
Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

  • China Inter-chemical.LTD [Manufacturers]
  • Tel: +86-755-25156137
  • Fax: +86-755-82187212
  • Address: Renmin Nan Road Shenzhen,GuangdongChina
Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

  • China Shanghai Biocompounds Chemlab [Manufacturers]
  • Tel: 86-21-57687675
  • Fax: 86-21-57687169
  • Address: 4/F No. 12 Building, 201 Minyi Road, Shanghai 201612, P. R. China Shanghai,ShanghaiChina
Contact Supplier

231277-92-2 LAPATINIB BASE

  • China Melone Pharmaceutical Co., Ltd. [Manufacturer]
  • Tel: +86-41182593631/ +86-41182702105
  • Fax: +86-41182593613
  • Address: Room 2209,No.232, Jinma Road,
    Development Zone,
    Dalian, China 116600 null,nullChina
Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

Contact Supplier

231277-92-2 Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine

Contact Supplier

Select to

8/10
Previous 1 2 3 4 5 6 7 8 9 10 Next
References of N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-
methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
Title: Lapatinib
CAS Registry Number: 231277-92-2
CAS Name: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine
Manufacturers' Codes: GW-572016
Trademarks: Tykerb (GSK)
Molecular Formula: C29H26ClFN4O4S
Molecular Weight: 581.06
Percent Composition: C 59.94%, H 4.51%, Cl 6.10%, F 3.27%, N 9.64%, O 11.01%, S 5.52%
Literature References: Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Prepn: M. C. Carter et al., WO 9935146 (1999 to Glaxo); eidem, US 6727256 (2004 to SmithKline Beecham). Mechanism of action study: W. Xia et al., Oncogene 21, 6255 (2002); and crystal structure in complex with epidermal growth factor receptor (EGFR, ErbB1): E. R. Wood et al., Cancer Res. 64, 6652 (2004). In vitro antitumor activity in combination with anti-ErbB2 antibodies: W. Xia et al., Oncogene 24, 6213 (2005). Biologic effects on tumor growth: N. L. Spector et al., J. Clin. Oncol. 23, 2502 (2005). Pharmacokinetics and clinical activity in metastatic carcinomas: H. A. Burris III et al., ibid. 5305. Review of clinical development: T. E. Kim, J. R. Murren, IDrugs 6, 886-893 (2003); H. A. Burris III, Oncologist 9, Suppl. 3, 10-15 (2004).
 
Derivative Type: Ditoluenesulfonate monohydrate
CAS Registry Number: 388082-78-8; 388082-77-7 (anhydrous)
Synonyms: Lapatinib ditosylate
Manufacturers' Codes: GW-572016F
Molecular Formula: C29H26ClFN4O4S.2C7H8O3S.H2O
Molecular Weight: 943.48
Percent Composition: C 54.74%, H 4.70%, Cl 3.76%, F 2.01%, N 5.94%, O 18.65%, S 10.20%
Properties: Yellow solid.
 
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Tyrosine Kinase Inhibitors.